世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

詳細検索

詳細検索

×

キーワード検索の使い方

×
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
日
お問い合わせ お問い合わせ

分散型臨床試験市場レポート：2026-2036年

分散型臨床試験市場レポート：2026-2036年


Decentralised Clinical Trials Market Report 2026-2036

概要 Visiongainは新たなレポートを発表しました。 分散型臨床試験市場レポート 2026-2036年 、世界の分散型臨床試験市場について、市場規模、成長要因、競合状況、および主要技術、適応症、エンドユ... もっと見る

　

　

出版社
Visiongain
ヴィジョンゲイン社
出版年月
2026年3月23日
電子版価格
GBP5,150
PDF版
ライセンス・価格情報／注文方法はこちら
納期
2営業日程度
ページ数
385
言語
英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

概要

Visiongainは新たなレポートを発表しました。分散型臨床試験市場レポート 2026-2036年、世界の分散型臨床試験市場について、市場規模、成長要因、競合状況、および主要技術、適応症、エンドユーザー別の収益予測を含む包括的な分析を提供しています。

世界の分散型臨床試験市場は、2026年の113億米ドルから、2036年には335億米ドルへと、年平均成長率（CAGR）11.5％で拡大する見込み…これにより、分散型モデルが臨床開発の主流に定着するにつれ、予測期間中に市場規模はほぼ倍増すると見込まれる。

この成長は、デジタルヘルス技術の継続的な進歩、患者中心型およびハイブリッド型臨床試験モデルの普及拡大、ならびに臨床試験の効率化と患者の関与向上に向けた遠隔モニタリングやリアルタイムデータ収集への依存度の高まりによって牽引されています。

技術革新が市場の拡大を牽引している

デジタルヘルス技術の急速な進歩により、分散型臨床試験市場の競争環境は一変しつつある。ウェアラブル端末、モバイルヘルスプラットフォーム、クラウドベースのシステムにより、継続的かつリアルタイムなデータ収集が可能となり、従来の施設での評価への依存度が低下し、試験の拡張性が向上している。

同時に、AIと高度な分析技術の統合により、予測的モニタリングや適応型試験デザインが支えられており、これにより組織はデータ品質の向上、期間の短縮、そして臨床プログラム全体における意思決定の強化を図ることが可能になっています。

貿易、政策、およびサプライチェーンの動向

  • 分散型臨床試験市場は、世界的な貿易動向、規制の枠組み、そして地政学的な情勢の変化の影響をますます強く受けている。
  • この市場は、ネットワーク接続型医療機器、センサー、デジタルインフラに大きく依存しており、主要地域における関税、輸出規制、規制の相違といったリスクにさらされている。
  • 電子機器や医療用部品に対する最近の関税措置により、臨床試験を可能にする技術のコストが上昇し、治験依頼者や受託研究機関に負担がかかっているほか、コスト面での不確実性がさらに高まっている。
  • 製薬業界のような規制の厳しい分野では、承認プロセスや方針決定に加え、GDPRやHIPAAといったデータ保護の枠組みへの準拠が、市場参入や業務遂行に引き続き大きな影響を与え続けている。

ビジネスへの影響

  • コストと価格圧力： デバイス、技術、およびコンプライアンス関連のコスト上昇が、臨床試験の予算に影響を及ぼしている
  • サプライチェーンの変化： 企業は調達先を多様化し、より強靭なデジタルインフラへの投資を進めている
  • 規制の影響： 市場のタイムラインとアクセスは、変化し続ける世界的なコンプライアンス要件によって左右される
  • 競合優位性： デジタルイノベーションや規制基準に対応している企業は、より有利な立場にある

企業情報

分散型臨床試験市場は、確立されたテクノロジープロバイダー、医薬品開発受託機関（CRO）、そして新興のデジタルヘルスプラットフォームが混在しており、各社がイノベーション、拡張性、規制対応能力の面で競い合っているのが特徴です。

Medable、Science 37、IQVIA、Parexelといった主要企業は、プラットフォームの開発、戦略的提携、そしてハイブリッド型および完全分散型臨床試験モデルへの展開を通じて、その地位を強化している。

競争は、ますます次のような要素によって特徴づけられるようになっている：

  • テクノロジープラットフォームの機能と統合
  • 規制およびデータコンプライアンスに関する専門知識
  • 世界的な事業展開と拡張性
  • ハイブリッド型および患者中心型の臨床試験モデルに対応できる能力

一方で、デジタルイノベーション、柔軟性、あるいはコスト面での優位性によって差別化を図れる分野では、新規参入企業や専門プロバイダーが勢いを増している。

本レポートでは、競争上のポジショニングがどのように変化しているかを分析し、価値がどこで創出されているか、また予測期間中に戦略がどのように変化すると予想されるかを明らかにする。

主な質問への回答

  • 2036年までの分散型臨床試験市場の規模はどの程度になると予測されていますか？
  • どのセグメントや地域が成長を牽引するのでしょうか？
  • デジタルヘルス技術とハイブリッドモデルは、市場の進化をどのように形作るのでしょうか？
  • 貿易、政策、サプライチェーンの動向は、コストや導入にどのような影響を与えるでしょうか？
  • 主要企業はどこか、またその地位は今後どのように変化していくのか？

レポートの範囲とデータの対象範囲

  • 世界の分散型臨床試験市場の分析
  • 2036年までの売上高予測
  • 研究デザイン、適応症、技術、およびエンドユーザーにわたるセグメントレベルのモデリング
  • 地域別および全国市場の予測
  • 主要企業に関する競合情報

定量的な予測と定性的な戦略分析の両方を含み、技術、競争、政策、サプライチェーンの動向を網羅しています。

セグメンテーション・フレームワーク

研究デザイン

  • 観察的
  • インターベンショナル
  • アクセス拡大

適応別

  • 腫瘍学
  • 心血管
  • 免疫学
  • 呼吸器系
  • その他

テクノロジー

  • 遠隔医療
  • モバイルヘルスケア
  • ウェアラブルデバイス
  • Webベースの
  • その他

エンドユーザー別

  • 製薬・バイオ医薬品企業
  • 臨床研究機関
  • その他

対象地域

北米

  • アメリカ合衆国
  • カナダ

欧州

  • ドイツ
  • フランス
  • イギリス
  • イタリア
  • スペイン
  • ロシア
  • ポーランド
  • ベルギー
  • スイス
  • オランダ
  • その他の地域

アジア太平洋

  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • シンガポール
  • 台湾
  • ニュージーランド
  • マレーシア
  • その他のアジア太平洋地域

ラテンアメリカ

  • ブラジル
  • メキシコ
  • アルゼンチン
  • コロンビア
  • チリ
  • その他のラテンアメリカ地域

中東・アフリカ

  • GCC
  • 南アフリカ
  • エジプト
  • その他の中東・アフリカ地域

分散型臨床試験市場レポート 2026-2036年

企業情報 対象範囲

本レポートには、以下のような主要企業の詳細なプロファイルが掲載されています：

  • 4G Clinical
  • Advarra Inc.
  • Clario
  • ICON PLC
  • IQVIA Inc.
  • Medable, Inc.
  • Oracle Corporation
  • Parexel International Corporation
  • Science 37
  • Veeva Systems

各プロフィールには以下の内容が含まれます：

  • 事業概要
  • 財務および市場における位置づけ
  • 製品および技術力
  • 戦略的展望

オーダーメイドのインテリジェンスとカスタマイズ

Visiongainでは、お客様の具体的なご要望に合わせた情報分析およびアドバイザリーサービスも提供しています。

これには以下が含まれます：

  • カスタマイズされた市場セグメンテーションと予測
  • 競合他社とのベンチマークおよび戦略分析
  • 政策および規制の影響評価
  • サプライチェーンおよび調達インテリジェンス
  • 関税や地政学的リスクを含むシナリオ・モデリング

この市場情報が重要な理由

  • デジタルトランスフォーメーション、規制の変更、そして臨床開発モデルの変容を背景に、分散型臨床試験市場は急速に進化しています。
  • こうした力学を理解している組織は、成長の機会を捉え、リスクを管理し、競争力を強化する上で、より有利な立場に立つことができるでしょう。


お問合せ種類／内容 *

補足が有ればご記入ください
貴社名*
ご担当者名 * 姓 名
メールアドレス *

ページTOPに戻る


目次

1 レポートの概要
1.1 本調査の目的
1.2 分散型臨床試験市場の概要
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主要な質問
1.6 本レポートの対象読者
1.7 調査方法
1.7.1 市場の定義
1.7.2 市場評価および予測の方法論
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 二次調査
1.8 よくある質問（FAQ）
1.9 関連するVisiongainレポート
1.10 Visiongainについて

2 概要

3 市場の概要
3.1 主な調査結果
3.2 市場の動向
3.3 影響分析
3.3.1 市場の推進要因
3.3.1.1 デジタルヘルス技術の進歩
3.3.1.2 臨床試験のグローバル化
3.3.1.3 患者中心型およびハイブリッド型試験モデルによる分散型臨床試験の導入加速
3.3.1.4 規制面での支援とガイダンスの進化
3.3.2 市場の抑制要因
3.3.2.1 データプライバシーおよびセキュリティに関する懸念
3.3.2.2 技術的制約と標準化
3.3.2.3 インフラおよびリソースの制約
3.3.3 市場の機会
3.3.3.1 医薬品開発とイノベーションの加速
3.3.3.2 新興市場への臨床試験活動の拡大
3.3.3.3 製薬会社間の提携および協業の増加
3.4 米国の関税：世界の分散型臨床試験市場への影響は？
3.4.1 概要
3.4.2 V字型回復シナリオ
3.4.2.1 なぜV字型回復なのか？
3.4.2.2 関税による影響
3.4.2.3 市場の動向と需要の回復
3.4.2.4 政策および資金支援
3.4.2.5 回復までの期間
3.4.3 U字型回復シナリオ
3.4.3.1 なぜU字型回復なのか？
3.4.3.2 関税の影響
3.4.3.3 市場の動向と需要の回復
3.4.3.4 政策および資金支援
3.4.3.5 回復までの期間
3.4.4 L字型回復シナリオ
3.4.4.1 なぜL字型回復なのか？
3.4.4.2 関税の影響
3.4.4.3 市場の動向と需要の回復
3.4.4.4 政策および資金支援
3.4.4.5 回復までの期間
3.4.5 クライアントは、短期（2025～2030年）および長期（2025～2035年）の計画において、どのような戦略的考慮事項を盛り込むべきか？
3.4.6 米国と中国の貿易戦争が分散型臨床試験市場に与える影響
3.4.7 最も影響を受ける国々は、これらの政策変更によってどのようなプラスおよびマイナスの影響を受ける可能性があるか？
3.5 ポーターの5つの力分析
3.5.1 供給者の交渉力
3.5.2 購入者の交渉力
3.5.3 競合他社間の競争
3.5.4 代替品の脅威
3.5.5 新規参入者の脅威
3.6 PEST分析

研究デザイン別分散型臨床試験市場分析（2024年12月4日）
4.1 主な調査結果
4.2 試験デザイン別セグメント：市場魅力度指数
4.3 試験デザイン別の分散型臨床試験市場規模の推計と予測
4.4 介入試験
4.4.1 地域別市場規模（2026年～2036年）（10億米ドル）
4.4.2 地域別市場シェア、2026年および2036年（％）
4.5 観察研究
4.5.1 地域別市場規模、2026年～2036年（10億米ドル）
4.5.2 地域別市場シェア、2026年および2036年（％）
4.6 拡大アクセス
4.6.1 地域別市場規模、2026年～2036年（10億米ドル）
4.6.2 地域別市場シェア、2026年および2036年（％）

適応症別分散型臨床試験市場分析（2023年12月5日）
5.1 主な調査結果
5.2 適応症セグメント：市場魅力度指数
5.3 適応症別分散型臨床試験市場の規模推計および予測
5.4 腫瘍学
5.4.1 地域別市場規模（2026年～2036年）（10億米ドル）
5.4.2 地域別市場シェア、2026年および2036年（％）
5.5 循環器
5.5.1 地域別市場規模、2026-2036年（10億米ドル）
5.5.2 地域別市場シェア、2026年および2036年（％）
5.6 免疫学
5.6.1 地域別市場規模、2026年～2036年（10億米ドル）
5.6.2 地域別市場シェア、2026年および2036年（％）
5.7 呼吸器系
5.7.1 地域別市場規模、2026年～2036年（10億米ドル）
5.7.2 地域別市場シェア、2026年および2036年（％）
5.8 その他
5.8.1 地域別市場規模、2026年～2036年（10億米ドル）
5.8.2 地域別市場シェア、2026年および2036年（％）

技術別分散型臨床試験市場分析（2023年12月6日）
6.1 主な調査結果
6.2 技術セグメント：市場魅力度指数
6.3 技術別分散型臨床試験の市場規模推計および予測
6.4 遠隔医療
6.4.1 地域別市場規模（2026年～2036年、10億米ドル）
6.4.2 地域別市場シェア、2026年および2036年（％）
6.5 モバイルヘルスケア
6.5.1 地域別市場規模、2026年～2036年（10億米ドル）
6.5.2 地域別市場シェア、2026年および2036年（％）
6.6 ウェアラブルデバイス
6.6.1 地域別市場規模、2026年～2036年（10億米ドル）
6.6.2 地域別市場シェア、2026年および2036年（％）
6.7 ウェブベース技術
6.7.1 地域別市場規模、2026年～2036年（10億米ドル）
6.7.2 地域別市場シェア、2026年および2036年（％）
6.8 その他
6.8.1 地域別市場規模、2026-2036年（10億米ドル）
6.8.2 地域別市場シェア、2026年および2036年（％）

エンドユーザー別分散型臨床試験市場分析（2023年12月7日）
7.1 主な調査結果
7.2 エンドユーザー別セグメント：市場魅力度指数
7.3 エンドユーザー別の分散型臨床試験市場規模の推計と予測
7.4 製薬・バイオ医薬品企業
7.4.1 地域別市場規模（2026年～2036年）（10億米ドル）
7.4.2 地域別市場シェア、2026年および2036年（％）
7.5 臨床研究機関（CRO）
7.5.1 地域別市場規模、2026年～2036年（10億米ドル）
7.5.2 地域別市場シェア、2026年および2036年（％）
7.6 その他
7.6.1 地域別市場規模、2026年～2036年（10億米ドル）
7.6.2 地域別市場シェア、2026年および2036年（％）

地域別分散型臨床試験市場分析（2023年12月8日）
8.1 主な調査結果
8.2 地域別市場規模の推計と予測

9 北米の分散型臨床試験市場分析
9.1 主な調査結果
9.2 北米分散型臨床試験市場の市場魅力度指数
9.3 北米分散型臨床試験市場：国別、2025年、2031年、2036年（10億米ドル）
9.4 北米分散型臨床試験市場の規模推計および予測（国別）
9.5 北米分散型臨床試験市場の規模推計および予測（試験デザイン別）
9.6 北米分散型臨床試験市場の規模推計および予測（適応症別）
9.7 北米分散型臨床試験市場の規模推計および予測（技術別）
9.8 北米分散型臨床試験市場の規模推計および予測（エンドユーザー別）
9.9 米国分散型臨床試験市場の分析
9.10 カナダ分散型臨床試験市場の分析

10 欧州の分散型臨床試験市場分析
10.1 主な調査結果
10.2 欧州の分散型臨床試験市場の魅力度指数
10.3 欧州の分散型臨床試験市場：国別、2026年、2031年、2036年（10億米ドル）
10.4 欧州の分散型臨床試験市場の規模推計および予測：国別
10.5 欧州分散型臨床試験市場の規模推計および予測（試験デザイン別）
10.6 欧州分散型臨床試験市場の規模推計および予測（適応症別）
10.7 欧州分散型臨床試験市場の規模推計および予測（技術別）
10.8 欧州分散型臨床試験市場の規模推計および予測（エンドユーザー別）
10.9 ドイツの分散型臨床試験市場分析
10.10 フランスの分散型臨床試験市場分析
10.11 英国の分散型臨床試験市場分析
10.12 イタリアの分散型臨床試験市場分析
10.13 スペインの分散型臨床試験市場分析
10.14 ロシアの分散型臨床試験市場分析
10.15 ポーランドの分散型臨床試験市場分析
10.16 ベルギーの分散型臨床試験市場分析
10.17 スイスの分散型臨床試験市場分析
10.18 オランダの分散型臨床試験市場分析
10.19 その他の欧州諸国の分散型臨床試験市場分析

11 アジア太平洋地域の分散型臨床試験市場分析
11.1 主な調査結果
11.2 アジア太平洋地域の分散型臨床試験市場の魅力度指数
11.3 アジア太平洋地域の分散型臨床試験市場：国別、2026年、2031年、2036年（10億米ドル）
11.4 アジア太平洋地域の分散型臨床試験市場規模の推計および予測（国別）
11.5 アジア太平洋地域の分散型臨床試験市場規模の推計および予測（試験デザイン別）
11.6 アジア太平洋地域の分散型臨床試験市場規模の推計および予測（適応症別）
11.7 アジア太平洋地域の分散型臨床試験市場規模の推計および予測（技術別）
11.8 アジア太平洋地域の分散型臨床試験市場規模の推計および予測（エンドユーザー別）
11.9 日本の分散型臨床試験市場分析
11.10 中国の分散型臨床試験市場分析
11.11 インドの分散型臨床試験市場分析
11.12 オーストラリアの分散型臨床試験市場分析
11.13 韓国における分散型臨床試験市場の分析
11.14 シンガポールにおける分散型臨床試験市場の分析
11.15 台湾における分散型臨床試験市場の分析
11.16 ニュージーランドにおける分散型臨床試験市場の分析
11.17 マレーシアにおける分散型臨床試験市場の分析
11.18 その他のアジア太平洋地域における分散型臨床試験市場の分析

12 ラテンアメリカの分散型臨床試験市場分析
12.1 主な調査結果
12.2 ラテンアメリカにおける分散型臨床試験市場の魅力度指数
12.3 ラテンアメリカにおける分散型臨床試験市場：国別、2026年、2031年、2036年（10億米ドル）
12.4 ラテンアメリカにおける分散型臨床試験市場の規模推計および予測：国別
12.5 ラテンアメリカ分散型臨床試験市場の規模推計および予測（試験デザイン別）
12.6 ラテンアメリカ分散型臨床試験市場の規模推計および予測（適応症別）
12.7 ラテンアメリカ分散型臨床試験市場の規模推計および予測（技術別）
12.8 ラテンアメリカ分散型臨床試験市場の規模推計および予測（エンドユーザー別）
12.9 ブラジルにおける分散型臨床試験市場の分析
12.10 メキシコにおける分散型臨床試験市場の分析
12.11 アルゼンチンにおける分散型臨床試験市場の分析
12.12 コロンビアにおける分散型臨床試験市場の分析
12.13 チリにおける分散型臨床試験市場の分析
12.14 その他のラテンアメリカ諸国における分散型臨床試験市場の分析

13 MEA 分散型臨床試験市場分析
13.1 主な調査結果
13.2 MEA分散型臨床試験市場の魅力度指数
13.3 MEA分散型臨床試験市場：国別、2026年、2031年、2036年（10億米ドル）
13.4 MEA分散型臨床試験市場の規模推計および予測（国別）
13.5 MEA分散型臨床試験市場の規模推計および予測（試験デザイン別）
13.6 MEA分散型臨床試験市場の規模推計および予測（適応症別）
13.7 MEA分散型臨床試験市場の規模推計および予測（技術別）
13.8 MEA地域における分散型臨床試験市場の規模推計および予測（エンドユーザー別）
13.9 GCC地域における分散型臨床試験市場の分析
13.10 南アフリカにおける分散型臨床試験市場の分析
13.11 エジプトにおける分散型臨床試験市場の分析
13.12 MEA地域のその他地域における分散型臨床試験市場の分析

14社の企業概要
14.1 2024年の競争環境
14.2 戦略的展望
14.3 4G Clinical
14.3.1 企業概要
14.3.2 会社概要
14.3.3 製品ベンチマーク
14.3.4 戦略的展望
14.4 Advarra Inc.
14.4.1 企業概要
14.4.2 会社概要
14.4.3 製品ベンチマーク
14.4.4 戦略的展望
14.5 Castor
14.5.1 企業概要
14.5.2 会社概要
14.5.3 ソリューションベンチマーク
14.5.4 戦略的展望
14.6 Clario
14.6.1 企業概要
14.6.2 会社概要
14.6.3 ソリューションのベンチマーク
14.6.4 戦略的展望
14.7 Clinical Ink
14.7.1 企業概要
14.7.2 会社概要
14.7.3 ソリューションのベンチマーク
14.7.4 戦略的展望
14.8 Cloudzbyz, Inc.
14.8.1 企業概要
14.8.2 会社概要
14.8.3 製品のベンチマーク
14.8.4 戦略的展望
14.9 Dassault Systemes SE (Medidata Solutions, Inc.)
14.9.1 企業概要
14.9.2 会社概要
14.9.3 財務分析
14.9.3.1 純売上高（2021年～2024年）
14.9.3.2 研究開発費（2021年～2024年）
14.9.3.3 地域別市場シェア（2024年）
14.9.3.4 事業セグメント別市場シェア（2024年）
14.9.4 製品ベンチマーク
14.9.5 SWOT分析
14.9.6 戦略的展望
14.10 エルゴメッド・グループ
14.10.1 企業概要
14.10.2 会社概要
14.10.3 製品ベンチマーク
14.10.4 戦略的展望
14.11 フローレンス・ヘルスケア社
14.11.1 企業概要
14.11.2 会社概要
14.11.3 製品ベンチマーク
14.11.4 戦略的展望
14.12 アイコン社
14.12.1 企業概要
14.12.2 会社概要
14.12.3 財務分析
14.12.3.1 純売上高（2021年～2024年）
14.12.3.2 地域別市場シェア（2024年）
14.12.4 製品ベンチマーク
14.12.5 SWOT分析
14.12.6 戦略的展望
14.13 Iqvia Inc.
14.13.1 企業概要
14.13.2 会社概要
14.13.3 財務分析
14.13.3.1 純売上高（2022年～2025年）
14.13.3.2 地域別市場シェア（2024年）
14.13.3.3 事業セグメント別市場シェア（2025年）
14.13.4 製品ベンチマーク
14.13.5 SWOT分析
14.13.6 戦略的展望
14.14 KORE Wireless Group, Inc.
14.14.1 企業概要
14.14.2 会社概要
14.14.3 財務分析
14.14.3.1 純売上高、2021-2024年
14.14.3.2 地域別市場シェア、2024年
14.14.3.3 事業セグメント別市場シェア（2024年）
14.14.4 製品ベンチマーク
14.14.5 SWOT分析
14.14.6 戦略的展望
14.15 ラボコープ・ホールディングス
14.15.1 企業概要
14.15.2 会社概要
14.15.3 財務分析
14.15.3.1 純売上高（2022年～2025年）
14.15.3.2 地域別市場シェア（2024年）
14.15.3.3 事業セグメント別市場シェア（2024年）
14.15.4 製品ベンチマーク
14.15.5 SWOT分析
14.15.6 戦略的展望
14.16 メダブル社
14.16.1 企業概要
14.16.2 会社概要
14.16.3 製品ベンチマーク
14.16.4 戦略的展望
14.17 メドリオ社
14.17.1 企業概要
14.17.2 会社概要
14.17.3 製品ベンチマーク
14.17.4 戦略的展望
14.18 ノボテック・ヘルス・ホールディングス
14.18.1 企業概要
14.18.2 会社概要
14.18.3 製品ベンチマーク
14.18.4 戦略的展望
14.19 オラクル・コーポレーション（Oracle Life Sciences）
14.19.1 企業概要
14.19.2 会社概要
14.19.3 財務分析
14.19.3.1 純売上高、2022-2025年
14.19.3.2 研究開発費（R&D）、2022-2025年
14.19.3.3 地域別市場シェア、2024年
14.19.3.4 事業セグメント別市場シェア、2024年
14.19.4 製品ベンチマーク
14.19.5 SWOT分析
14.19.6 戦略的展望
14.20 パレクセル・インターナショナル（MA）コーポレーション
14.20.1 企業概要
14.20.2 会社概要
14.20.3 製品ベンチマーク
14.20.4 SWOT分析
14.20.5 戦略的展望
14.21 プロファーマ・グループMISリミテッド
14.21.1 企業概要
14.21.2 会社概要
14.21.3 製品ベンチマーキング
14.21.4 戦略的展望
14.22 サイエンス37ホールディングス社
14.22.1 企業概要
14.22.2 会社概要
14.22.3 製品ベンチマーク
14.22.4 戦略的展望
14.23 Signant Health
14.23.1 企業概要
14.23.2 会社概要
14.23.3 製品ベンチマーク
14.23.4 戦略的展望
14.24 サイネオス・ヘルス
14.24.1 企業概要
14.24.2 会社概要
14.24.3 製品ベンチマーク
14.24.4 戦略的展望
14.25 サーモフィッシャーサイエンティフィック社
14.25.1 企業概要
14.25.2 会社概要
14.25.3 財務分析
14.25.3.1 純売上高（2022年～2025年）
14.25.3.2 研究開発費（2022年～2025年）
14.25.3.3 地域別市場シェア（2024年）
14.25.3.4 事業セグメント別市場シェア（2024年）
14.25.4 製品ベンチマーク
14.25.5 SWOT分析
14.25.6 戦略的展望
14.26 TFS HealthScience
14.26.1 企業概要
14.26.2 会社概要
14.26.3 製品ベンチマーク
14.26.4 戦略的展望
14.27 THREAD Research
14.27.1 企業概要
14.27.2 会社概要
14.27.3 製品ベンチマーク
14.27.4 戦略的展望
14.28 Veeva Systems Inc.
14.28.1 企業概要
14.28.2 会社概要
14.28.3 財務分析
14.28.3.1 純売上高（2022年～2025年）
14.28.3.2 研究開発費（2021年～2024年）
14.28.3.3 地域別市場シェア（2025年）
14.28.3.4 事業セグメント別市場シェア（2025年）
14.28.4 製品ベンチマーク
14.28.5 SWOT分析
14.28.6 戦略的展望

15 結論と提言
15.1 Visiongainによる総括
15.2 市場関係者への提言

 

ページTOPに戻る



図表リスト

List of Tables
Table 1 Decentralised Clinical Trials Market Snapshot, 2026 & 2036 (US$ Million, CAGR %)
Table 2 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: V- Shaped Recovery Scenario
Table 3 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: U- Shaped Recovery Scenario
Table 4 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: L- Shaped Recovery Scenario
Table 5 Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 6 Interventional Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 7 Observational Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 8 Expanded Access Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 9 Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 10 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 11 Cardiovascular Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 12 Immunology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 13 Respiratory Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 14 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 15 Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 16 Telemedicine Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 17 Mobile Healthcare Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 18 Wearable Devices Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 19 Web-based Technology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 20 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 21 Decentralised Clinical Trials Market Forecast by End-User, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 22 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 23 Clinical Research Organisations (CROs) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 24 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 25 Decentralised Clinical Trials Market Forecast by Region, 2026-2036 (US$ Million, AGR%, CAGR%)
Table 26 North America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 27 North America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 28 North America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 29 North America Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 30 North America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 31 U.S. Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 32 Canada Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 33 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 34 Europe Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 35 Europe Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 36 Europe Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 37 Europe Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 38 Germany Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 39 France Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 40 UK Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 41 Italy Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 42 Spain Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 43 Russia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 44 Poland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 45 Belgium Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 46 Switzerland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 47 Netherland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 48 Rest of Europe Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 49 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 50 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 51 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 52 Asia Pacific Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 53 Asia Pacific Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 54 Japan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 55 China Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 56 India Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 57 Australia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 58 South Korea Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 59 Singapore Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 60 Taiwan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 61 New Zealand Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 62 Malaysia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 63 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 64 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 65 Latin America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 66 Latin America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 67 Latin America Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 68 Latin America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 69 Brazil Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 70 Mexico Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 71 Argentina Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 72 Colombia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 73 Chile Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 74 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 75 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 76 MEA Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 77 MEA Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 78 MEA Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 79 MEA Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 80 GCC Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 81 South Africa Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 82 Egypt Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 83 Rest of MEA Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 84 Strategic Outlook
Table 85 4G Clinical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 4G Clinical: Product Benchmarking
Table 87 4G Clinical: Strategic Outlook
Table 88 Advarra Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Advarra Inc.: Product Benchmarking
Table 90 Advarra: Strategic Outlook
Table 91 Castor: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Castor: Solutions Benchmarking
Table 93 Castor: Strategic Outlook
Table 94 Clario: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Clario: Solutions Benchmarking
Table 96 Clario: Strategic Outlook
Table 97 Clinical Ink: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Clinical Ink: Solutions Benchmarking
Table 99 Clinical Ink: Strategic Outlook
Table 100 Cloudzbyz, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Cloudzbyz, Inc.: Product Benchmarking
Table 102 Cloudzbyz, Inc.: Strategic Outlook
Table 103 Dassault Systemes SE (Medidata Solutions, Inc.): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Dassault Systemes SE (Medidata Solutions, Inc.): Product Benchmarking
Table 105 Dassault Systemes SE (Medidata Solutions, Inc.): SWOT Analysis
Table 106 Dassault Systemes SE (Medidata Solutions, Inc.): Strategic Outlook
Table 107 Ergomed Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Ergomed Group: Product Benchmarking
Table 109 Ergomed Group: Strategic Outlook
Table 110 Florence Healthcare, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Florence Healthcare, Inc.: Product Benchmarking
Table 112 Florence Healthcare, Inc.: Strategic Outlook
Table 113 Icon Plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Icon Plc: Product Benchmarking
Table 115 Icon Plc: SWOT Analysis
Table 116 Icon Plc: Strategic Outlook
Table 117 Iqvia Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Iqvia Inc.: Product Benchmarking
Table 119 Iqvia Inc.: SWOT Analysis
Table 120 Iqvia Inc.: Strategic Outlook
Table 121 KORE Wireless Group, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 KORE Wireless Group, Inc.: Product Benchmarking
Table 123 KORE Wireless Group, Inc.: SWOT Analysis
Table 124 KORE Wireless Group, Inc.: Strategic Outlook
Table 125 Labcorp Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Labcorp Holdings: Product Benchmarking
Table 127 Labcorp Holdings: SWOT Analysis
Table 128 Labcorp Holdings: Strategic Outlook
Table 129 Medable Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Medable Inc.: Product Benchmarking
Table 131 Medable Inc.: Strategic Outlook
Table 132 Medrio, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Medrio, Inc.: Product Benchmarking
Table 134 Medrio, Inc.: Strategic Outlook
Table 135 Novotech Health Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Novotech Health Holdings: Product Benchmarking
Table 137 Novotech Health Holdings: Strategic Outlook
Table 138 Oracle Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 139 Oracle Life Sciences: Product Benchmarking
Table 140 Oracle Life Sciences: SWOT Analysis
Table 141 Oracle Corporation: Strategic Outlook
Table 142 Parexel International (MA) Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 143 Parexel International (MA) Corporation: Product Benchmarking
Table 144 Parexel International (MA) Corporation: SWOT Analysis
Table 145 Parexel International (MA) Corporation: Strategic Outlook
Table 146 ProPharma Group MIS Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 147 ProPharma Group MIS Limited: Product Benchmarking
Table 148 ProPharma Group MIS Limited: Strategic Outlook
Table 149 Science 37 Holdings, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 150 Science 37 Holdings, Inc.: Product Benchmarking
Table 151 Science 37 Holdings, Inc.: Strategic Outlook
Table 152 Signant Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 153 Signant Health: Product Benchmarking
Table 154 Signant Health: Strategic Outlook
Table 155 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 156 Syneos Health: Product Benchmarking
Table 157 Syneos Health: Strategic Outlook
Table 158 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 159 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 160 Thermo Fisher Scientific Inc.: SWOT Analysis
Table 161 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 162 TFS HealthScience: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 163 TFS HealthScience: Product Benchmarking
Table 164 TFS HealthScience: Strategic Outlook
Table 165 THREAD Research: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 THREAD Research: Product Benchmarking
Table 167 THREAD Research: Strategic Outlook
Table 168 Veeva Systems Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 169 Veeva Systems Inc.: Product Benchmarking
Table 170 Veeva Systems Inc.: SWOT Analysis
Table 171 Veeva Systems Inc.: Strategic Outlook

List of Figures
Figure 1 Decentralised Clinical Trials Market Segmentation
Figure 2 Decentralised Clinical Trials Market by Study-Design: Market Attractiveness Index
Figure 3 Decentralised Clinical Trials Market by Indication: Market Attractiveness Index
Figure 4 Decentralised Clinical Trials Market by Technology: Market Attractiveness Index
Figure 5 Decentralised Clinical Trials Market by End-users: Market Attractiveness Index
Figure 6 Decentralised Clinical Trials Market by Region: Market Attractiveness Index
Figure 7 Decentralised Clinical Trials Market: Market Dynamics
Figure 8 Decentralised Clinical Trials Market: Impact Analysis
Figure 9 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 10 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 11 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 12 Short Term & Long Term Planning
Figure 13 Impact of U.S. and China Trade War
Figure 14 Most Impacted Countries
Figure 15 Decentralised Clinical Trials Market: Porter’s Five Forces Analysis
Figure 16 Decentralised Clinical Trials Market: PEST Analysis
Figure 17 Decentralised Clinical Trials Market by Study Design: Market Attractiveness Index
Figure 18 Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 19 Decentralised Clinical Trials Market Share Forecast by Study Design, 2026, 2031, 2036 (%)
Figure 20 Interventional Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 21 Interventional Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 22 Observational Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 23 Observational Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 24 Expanded Access Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 25 Expanded Access Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 26 Decentralised Clinical Trials Market by Indication: Market Attractiveness Index
Figure 27 Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 28 Decentralised Clinical Trials Market Share Forecast by Indication, 2026, 2031, 2036 (%)
Figure 29 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 30 Oncology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 31 Cardiovascular Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 32 Cardiovascular Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 33 Immunology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 34 Immunology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 35 Respiratory Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 36 Respiratory Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 37 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 38 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 39 Decentralised Clinical Trials Market by Technology: Market Attractiveness Index
Figure 40 Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 41 Decentralised Clinical Trials Market Share Forecast by Technology, 2026, 2031, 2036 (%)
Figure 42 Telemedicine Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 43 Telemedicine Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 44 Mobile Healthcare Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 45 Mobile Healthcare Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 46 Wearable Devices Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 47 Wearable Devices Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 48 Web-based Technology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 49 Web-based Technology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 50 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 51 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 52 Decentralised Clinical Trials Market by End-User: Market Attractiveness Index
Figure 53 Decentralised Clinical Trials Market Forecast by End-User, 2026-2036 (US$ Billion, AGR %)
Figure 54 Decentralised Clinical Trials Market Share Forecast by End-User, 2026, 2031, 2036 (%)
Figure 55 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 56 Pharmaceutical and Biopharmaceutical Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 57 Clinical Research Organisations (CROs) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 58 Clinical Research Organisations (CROs) Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 59 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 60 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 61 Decentralised Clinical Trials Market Forecast by Region 2025 and 2036 (Revenue, CAGR%)
Figure 62 Decentralised Clinical Trials Market Share Forecast by Region 2026, 2031, 2036 (%)
Figure 63 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %)
Figure 64 North America Decentralised Clinical Trials Market Attractiveness Index
Figure 65 North America Decentralised Clinical Trials Market by Region, 2025, 2031 & 2036 (US$ Billion)
Figure 66 North America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 67 North America Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 68 North America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 69 North America Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 70 North America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 71 North America Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 72 North America Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 73 North America Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 74 North America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 75 North America Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 76 U.S. Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 77 Canada Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 78 Europe Decentralised Clinical Trials Market Attractiveness Index
Figure 79 Europe Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 80 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 81 Europe Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 82 Europe Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 83 Europe Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 84 Europe Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 85 Europe Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 86 Europe Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 87 Europe Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 88 Europe Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 89 Europe Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 90 Germany Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 91 France Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 92 UK Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 93 Italy Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 94 Spain Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 95 Russia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 96 Poland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 97 Belgium Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 98 Switzerland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 99 Netherland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 100 Rest of Europe Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 101 Asia Pacific Decentralised Clinical Trials Market Attractiveness Index
Figure 102 Asia Pacific Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 103 Asia Pacific Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 104 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 105 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 106 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 107 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 108 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 109 Asia Pacific Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 110 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 111 Asia Pacific Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 112 Asia Pacific Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 113 Japan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 114 China Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 115 India Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 116 Australia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 117 South Korea Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 118 Singapore Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 119 Taiwan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 120 New Zealand Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 121 Malaysia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 122 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 123 Latin America Decentralised Clinical Trials Market Attractiveness Index
Figure 124 Latin America Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 125 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 126 Latin America Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 127 Latin America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 128 Latin America Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 129 Latin America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 130 Latin America Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 131 Latin America Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 132 Latin America Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 133 Latin America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 134 Latin America Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 135 Brazil Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 136 Mexico Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 137 Argentina Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 138 Colombia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 139 Chile Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 140 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 141 MEA Decentralised Clinical Trials Market Attractiveness Index
Figure 142 MEA Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 143 MEA Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 144 MEA Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 145 MEA Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 146 MEA Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 147 MEA Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 148 MEA Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 149 MEA Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 150 MEA Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 151 MEA Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 152 MEA Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 153 GCC Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 154 South Africa Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 155 Egypt Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 156 Rest of MEA Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 157 Decentralised Clinical Trials Market: Company Share/Ranking, 2024
Figure 158 Dassault Systemes SE (Medidata Solutions, Inc.): Net Revenue, 2021-2024 (US$ Million, AGR%)
Figure 159 Dassault Systemes SE (Medidata Solutions, Inc.): R&D, 2021-2024 (US$ Million, AGR%)
Figure 160 Dassault Systemes SE (Medidata Solutions, Inc.): Regional Market Shares, 2024
Figure 161 Dassault Systemes SE (Medidata Solutions, Inc.): Business Segment Market Shares, 2024
Figure 162 Icon Plc: Net Revenue, 2021-2024 (US$ Million, AGR%)
Figure 163 Icon Plc: Regional Market Shares, 2024
Figure 164 Iqvia Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 165 Iqvia Inc.: Regional Market Shares, 2024
Figure 166 Iqvia Inc.: Business Segment Market Shares, 2025
Figure 167 KORE Wireless Group, Inc.: Net Revenue, 2021-2024 (US$ Million, AGR%)
Figure 168 KORE Wireless Group, Inc.: Regional Market Shares, 2024
Figure 169 KORE Wireless Group, Inc.: Business Segment Market Shares, 2024
Figure 170 Labcorp Holdings: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 171 Labcorp Holdings: Regional Market Shares, 2024
Figure 172 Labcorp Holdings: Business Segment Market Shares, 2024
Figure 173 Oracle Life Sciences: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 174 Oracle Life Sciences: R&D, 2022-2025 (US$ Million, AGR%)
Figure 175 Oracle Life Sciences: Regional Market Shares, 2025
Figure 176 Oracle Life Sciences: Business Segment Market Shares, 2025
Figure 177 Thermo Fisher Scientific Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 178 Thermo Fisher Scientific Inc.: R&D, 2022-2025 (US$ Million, AGR%)
Figure 179 Thermo Fisher Scientific Inc.: Regional Market Shares, 2024
Figure 180 Thermo Fisher Scientific Inc.: Business Segment Market Shares, 2024
Figure 181 Veeva Systems Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 182 Veeva Systems Inc.: R&D, 2022-2025 (US$ Million, AGR%)
Figure 183 Veeva Systems Inc.: Regional Market Shares, 2025
Figure 184 Veeva Systems Inc.: Business Segment Market Shares, 2025

 

　

ページTOPに戻る


　

Summary

Description

Visiongain has published a new report, Decentralised Clinical Trials Market Report 2026-2036, providing a comprehensive analysis of the global decentralised clinical trials market, including market size, growth drivers, competitive positioning, and revenue forecasts across key technologies, indications, and end users.

The global decentralised clinical trials market is expected to grow from US$11.3bn in 2026 to US$33.5bn by 2036, at a CAGR of 11.5%, representing a near doubling of the market over the forecast period as decentralised models become embedded in mainstream clinical development.

This growth is driven by continued advancement in digital health technologies, increasing adoption of patient-centric and hybrid trial models, and growing reliance on remote monitoring and real-time data capture to improve trial efficiency and patient engagement.

Technological Innovation Driving Market Expansion

Rapid advances in digital health technologies are reshaping the competitive landscape of the decentralised clinical trials market. Wearables, mobile health platforms, and cloud-based systems are enabling continuous, real-time data collection, reducing reliance on traditional site-based assessments and improving trial scalability.

At the same time, integration of AI and advanced analytics is supporting predictive monitoring and adaptive trial design, helping organisations improve data quality, reduce timelines, and enhance decision-making across clinical programmes.

Trade, Policy & Supply Chain Dynamics

  • The decentralised clinical trials market is increasingly influenced by global trade dynamics, regulatory frameworks, and geopolitical developments.
  • The market depends heavily on connected medical devices, sensors, and digital infrastructure, creating exposure to tariffs, export controls, and regulatory variation across key regions.
  • Recent tariff measures on electronics and medical components have increased the cost of trial-enabling technologies, placing pressure on sponsors and contract research organisations and contributing to broader cost uncertainty.
  • In regulated sectors such as pharmaceuticals, compliance with data protection frameworks such as GDPR and HIPAA, alongside approval processes and policy decisions, continues to shape market access and operational execution.

Commercial Impact

  • Cost and pricing pressure: Rising device, technology, and compliance costs are impacting trial budgets
  • Supply chain shifts: Organisations are diversifying sourcing and investing in more resilient digital infrastructure
  • Regulatory influence: Market timelines and access are shaped by evolving global compliance requirements
  • Competitive positioning: Companies aligned with digital innovation and regulatory standards are better positioned

Company Intelligence

The decentralised clinical trials market is characterised by a mix of established technology providers, contract research organisations, and emerging digital health platforms competing across innovation, scalability, and regulatory capability.

Leading companies including Medable, Science 37, IQVIA, and Parexel are strengthening their positions through platform development, strategic partnerships, and expansion into hybrid and fully decentralised trial models.

Competition is increasingly defined by:

  • Technology platform capability and integration
  • Regulatory and data compliance expertise
  • Global operational reach and scalability
  • Ability to support hybrid and patient-centric trial models

At the same time, newer entrants and specialist providers are gaining traction where digital innovation, flexibility, or cost advantage create differentiation.

This report analyses how competitive positioning is evolving, identifying where value is being created and how strategies are expected to shift over the forecast period.

Key Questions Answered

  • What is the projected size of the decentralised clinical trials market by 2036?
  • Which segments and regions will drive growth?
  • How will digital health technologies and hybrid models shape market evolution?
  • How will trade, policy, and supply chain dynamics impact costs and deployment?
  • Who are the leading companies and how will their positions evolve?

Report Scope and Data Coverage

  • Global decentralised clinical trials market analysis
  • Revenue forecasts to 2036
  • Segment-level modelling across study design, indication, technology, and end user
  • Regional and national market forecasts
  • Competitive intelligence on leading companies

Includes both quantitative forecasting and qualitative strategic analysis, covering technology, competition, policy, and supply chain dynamics.

Segmentation Framework

By Study Design

  • Observational
  • Interventional
  • Expanded Access

By Indication

  • Oncology
  • Cardiovascular
  • Immunology
  • Respiratory
  • Others

By Technology

  • Telemedicine
  • Mobile Healthcare
  • Wearable Devices
  • Web-Based
  • Others

By End-user

  • Pharmaceutical & Biopharmaceutical Companies
  • Clinical Research Organisations
  • Others

Geographic Coverage

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Belgium
  • Switzerland
  • Netherlands
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
  • Taiwan
  • New Zealand
  • Malaysia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Egypt
  • Rest of Middle East & Africa

Decentralised Clinical Trials Market Report 2026-2036

Company Intelligence Coverage

This report includes detailed profiles of leading companies such as:

  • 4G Clinical
  • Advarra Inc.
  • Clario
  • ICON PLC
  • IQVIA Inc.
  • Medable, Inc.
  • Oracle Corporation
  • Parexel International Corporation
  • Science 37
  • Veeva Systems

Each profile includes:

  • Business overview
  • Financial and market positioning
  • Product and technology capabilities
  • Strategic outlook

Bespoke Intelligence & Customisation

Visiongain also provides tailored intelligence and advisory support aligned to specific client requirements.

This includes:

  • Custom market segmentation and forecasts
  • Competitive benchmarking and strategy analysis
  • Policy and regulatory impact assessment
  • Supply chain and sourcing intelligence
  • Scenario modelling including tariffs and geopolitical risk

Why This Market Intelligence Matters

  • The decentralised clinical trials market is evolving rapidly, driven by digital transformation, regulatory change, and shifting clinical development models.
  • Organisations that understand these dynamics will be better positioned to capture growth opportunities, manage risk, and strengthen competitive positioning.


ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Decentralised Clinical Trials Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Advancements in Digital Health Technologies
3.3.1.2 Globalisation of Clinical Trials
3.3.1.3 Patient-Centric and Hybrid Trial Models Accelerating Adoption of Decentralised Clinical Trials
3.3.1.4 Evolving Regulatory Support and Guidance
3.3.2 Market Restraining Factors
3.3.2.1 Data Privacy and Security Concerns
3.3.2.2 Technological Limitations and Standardization
3.3.2.3 Infrastructure and Resource Constraints
3.3.3 Market Opportunities
3.3.3.1 Acceleration of Drug Development and Innovation
3.3.3.2 Expansion of Clinical Trial Activities into Emerging Markets
3.3.3.3 Increasing Partnerships and Collaborations Between Pharmaceutical Companies
3.4 U.S. Tariffs: What’s the Impact on Global Decentralised Clinical Trials Market?
3.4.1 Overview
3.4.2 V-Shaped Recovery Scenario
3.4.2.1 Why V-Shaped Recovery?
3.4.2.2 Impact from Tariffs
3.4.2.3 Market Dynamics and Demand Recovery
3.4.2.4 Policy and Funding Support
3.4.2.5 Timeframe for Recovery
3.4.3 U-Shaped Recovery Scenario
3.4.3.1 Why U-Shaped Recovery?
3.4.3.2 Impact from Tariffs
3.4.3.3 Market Dynamics and Demand Recovery
3.4.3.4 Policy and Funding Support
3.4.3.5 Timeframe for Recovery
3.4.4 L Shaped Recovery Scenario
3.4.4.1 Why L-Shaped Recovery?
3.4.4.2 Impact from Tariffs
3.4.4.3 Market Dynamics and Demand Recovery
3.4.4.4 Policy and Funding Support
3.4.4.5 Timeframe for Recovery
3.4.5 What Strategic Considerations Should Clients Factor into Their Near-term (2025–2030) and Long-term (2025–2035) Planning?
3.4.6 Impact of U.S. and China Trade War on Decentralised Clinical Trials Market
3.4.7 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
3.5 Porter’s Five Forces Analysis
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitutes
3.5.5 Threat of New Entrants
3.6 PEST Analysis

4 Decentralised Clinical Trials Market Analysis by Study Design
4.1 Key Findings
4.2 Study Design Segment: Market Attractiveness Index
4.3 Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
4.4 Interventional
4.4.1 Market Size by Region, 2026-2036 (US$ Billion)
4.4.2 Market Share by Region, 2026 & 2036 (%)
4.5 Observational
4.5.1 Market Size by Region, 2026-2036 (US$ Billion)
4.5.2 Market Share by Region, 2026 & 2036 (%)
4.6 Expanded Access
4.6.1 Market Size by Region, 2026-2036 (US$ Billion)
4.6.2 Market Share by Region, 2026 & 2036 (%)

5 Decentralised Clinical Trials Market Analysis by Indication
5.1 Key Findings
5.2 Indication Segment: Market Attractiveness Index
5.3 Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
5.4 Oncology
5.4.1 Market Size by Region, 2026-2036 (US$ Billion)
5.4.2 Market Share by Region, 2026 & 2036 (%)
5.5 Cardiovascular
5.5.1 Market Size by Region, 2026-2036 (US$ Billion)
5.5.2 Market Share by Region, 2026 & 2036 (%)
5.6 Immunology
5.6.1 Market Size by Region, 2026-2036 (US$ Billion)
5.6.2 Market Share by Region, 2026 & 2036 (%)
5.7 Respiratory
5.7.1 Market Size by Region, 2026-2036 (US$ Billion)
5.7.2 Market Share by Region, 2026 & 2036 (%)
5.8 Others
5.8.1 Market Size by Region, 2026-2036 (US$ Billion)
5.8.2 Market Share by Region, 2026 & 2036 (%)

6 Decentralised Clinical Trials Market Analysis by Technology
6.1 Key Findings
6.2 Technology Segment: Market Attractiveness Index
6.3 Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
6.4 Telemedicine
6.4.1 Market Size by Region, 2026-2036 (US$ Billion)
6.4.2 Market Share by Region, 2026 & 2036 (%)
6.5 Mobile Healthcare
6.5.1 Market Size by Region, 2026-2036 (US$ Billion)
6.5.2 Market Share by Region, 2026 & 2036 (%)
6.6 Wearable Devices
6.6.1 Market Size by Region, 2026-2036 (US$ Billion)
6.6.2 Market Share by Region, 2026 & 2036 (%)
6.7 Web-based Technology
6.7.1 Market Size by Region, 2026-2036 (US$ Billion)
6.7.2 Market Share by Region, 2026 & 2036 (%)
6.8 Others
6.8.1 Market Size by Region, 2026-2036 (US$ Billion)
6.8.2 Market Share by Region, 2026 & 2036 (%)

7 Decentralised Clinical Trials Market Analysis by End-User
7.1 Key Findings
7.2 End-User Segment: Market Attractiveness Index
7.3 Decentralised Clinical Trials Market Size Estimation and Forecast by End-User
7.4 Pharmaceutical and Biopharmaceutical Companies
7.4.1 Market Size by Region, 2026-2036 (US$ Billion)
7.4.2 Market Share by Region, 2026 & 2036 (%)
7.5 Clinical Research Organisations (CROs)
7.5.1 Market Size by Region, 2026-2036 (US$ Billion)
7.5.2 Market Share by Region, 2026 & 2036 (%)
7.6 Others
7.6.1 Market Size by Region, 2026-2036 (US$ Billion)
7.6.2 Market Share by Region, 2026 & 2036 (%)

8 Decentralised Clinical Trials Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Decentralised Clinical Trials Market Analysis
9.1 Key Findings
9.2 North America Decentralised Clinical Trials Market Attractiveness Index
9.3 North America Decentralised Clinical Trials Market by Country, 2025, 2031 & 2036 (US$ Billion)
9.4 North America Decentralised Clinical Trials Market Size Estimation and Forecast by Country
9.5 North America Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
9.6 North America Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
9.7 North America Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
9.8 North America Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
9.9 U.S. Decentralised Clinical Trials Market Analysis
9.10 Canada Decentralised Clinical Trials Market Analysis

10 Europe Decentralised Clinical Trials Market Analysis
10.1 Key Findings
10.2 Europe Decentralised Clinical Trials Market Attractiveness Index
10.3 Europe Decentralised Clinical Trials Market by Country, 2026, 2031 & 2036 (US$ Billion)
10.4 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by Country
10.5 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
10.6 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
10.7 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
10.8 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
10.9 Germany Decentralised Clinical Trials Market Analysis
10.10 France Decentralised Clinical Trials Market Analysis
10.11 UK Decentralised Clinical Trials Market Analysis
10.12 Italy Decentralised Clinical Trials Market Analysis
10.13 Spain Decentralised Clinical Trials Market Analysis
10.14 Russia Decentralised Clinical Trials Market Analysis
10.15 Poland Decentralised Clinical Trials Market Analysis
10.16 Belgium Decentralised Clinical Trials Market Analysis
10.17 Switzerland Decentralised Clinical Trials Market Analysis
10.18 Netherland Decentralised Clinical Trials Market Analysis
10.19 Rest of Europe Decentralised Clinical Trials Market Analysis

11 Asia Pacific Decentralised Clinical Trials Market Analysis
11.1 Key Findings
11.2 Asia Pacific Decentralised Clinical Trials Market Attractiveness Index
11.3 Asia Pacific Decentralised Clinical Trials Market by Country, 2026, 2031 & 2036 (US$ Billion)
11.4 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by Country
11.5 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
11.6 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
11.7 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
11.8 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
11.9 Japan Decentralised Clinical Trials Market Analysis
11.10 China Decentralised Clinical Trials Market Analysis
11.11 India Decentralised Clinical Trials Market Analysis
11.12 Australia Decentralised Clinical Trials Market Analysis
11.13 South Korea Decentralised Clinical Trials Market Analysis
11.14 Singapore Decentralised Clinical Trials Market Analysis
11.15 Taiwan Decentralised Clinical Trials Market Analysis
11.16 New Zealand Decentralised Clinical Trials Market Analysis
11.17 Malaysia Decentralised Clinical Trials Market Analysis
11.18 Rest of Asia Pacific Decentralised Clinical Trials Market Analysis

12 Latin America Decentralised Clinical Trials Market Analysis
12.1 Key Findings
12.2 Latin America Decentralised Clinical Trials Market Attractiveness Index
12.3 Latin America Decentralised Clinical Trials Market by Country, 2026, 2031 & 2036 (US$ Billion)
12.4 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by Country
12.5 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
12.6 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
12.7 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
12.8 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
12.9 Brazil Decentralised Clinical Trials Market Analysis
12.10 Mexico Decentralised Clinical Trials Market Analysis
12.11 Argentina Decentralised Clinical Trials Market Analysis
12.12 Colombia Decentralised Clinical Trials Market Analysis
12.13 Chile Decentralised Clinical Trials Market Analysis
12.14 Rest of Latin America Decentralised Clinical Trials Market Analysis

13 MEA Decentralised Clinical Trials Market Analysis
13.1 Key Findings
13.2 MEA Decentralised Clinical Trials Market Attractiveness Index
13.3 MEA Decentralised Clinical Trials Market by Country, 2026, 2031 & 2036 (US$ Billion)
13.4 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by Country
13.5 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
13.6 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
13.7 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
13.8 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
13.9 GCC Decentralised Clinical Trials Market Analysis
13.10 South Africa Decentralised Clinical Trials Market Analysis
13.11 Egypt Decentralised Clinical Trials Market Analysis
13.12 Rest of MEA Decentralised Clinical Trials Market Analysis

14 Company Profiles
14.1 Competitive Landscape, 2024
14.2 Strategic Outlook
14.3 4G Clinical
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Product Benchmarking
14.3.4 Strategic Outlook
14.4 Advarra Inc.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Product Benchmarking
14.4.4 Strategic Outlook
14.5 Castor
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Solutions Benchmarking
14.5.4 Strategic Outlook
14.6 Clario
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Solutions Benchmarking
14.6.4 Strategic Outlook
14.7 Clinical Ink
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Solutions Benchmarking
14.7.4 Strategic Outlook
14.8 Cloudzbyz, Inc.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product Benchmarking
14.8.4 Strategic Outlook
14.9 Dassault Systemes SE (Medidata Solutions, Inc.)
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2021-2024
14.9.3.2 R&D, 2021-2024
14.9.3.3 Regional Market Shares, 2024
14.9.3.4 Business Segment Market Shares, 2024
14.9.4 Product Benchmarking
14.9.5 SWOT Analysis
14.9.6 Strategic Outlook
14.10 Ergomed Group
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.10.4 Strategic Outlook
14.11 Florence Healthcare, Inc.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Product Benchmarking
14.11.4 Strategic Outlook
14.12 Icon Plc
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2021-2024
14.12.3.2 Regional Market Shares, 2024
14.12.4 Product Benchmarking
14.12.5 SWOT Analysis
14.12.6 Strategic Outlook
14.13 Iqvia Inc.
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2022-2025
14.13.3.2 Regional Market Shares, 2024
14.13.3.3 Business Segment Market Shares, 2025
14.13.4 Product Benchmarking
14.13.5 SWOT Analysis
14.13.6 Strategic Outlook
14.14 KORE Wireless Group, Inc.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2021-2024
14.14.3.2 Regional Market Shares, 2024
14.14.3.3 Business Segment Market Shares, 2024
14.14.4 Product Benchmarking
14.14.5 SWOT Analysis
14.14.6 Strategic Outlook
14.15 Labcorp Holdings
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2022-2025
14.15.3.2 Regional Market Shares, 2024
14.15.3.3 Business Segment Market Shares, 2024
14.15.4 Product Benchmarking
14.15.5 SWOT Analysis
14.15.6 Strategic Outlook
14.16 Medable Inc.
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Product Benchmarking
14.16.4 Strategic Outlook
14.17 Medrio, Inc.
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Product Benchmarking
14.17.4 Strategic Outlook
14.18 Novotech Health Holdings
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Product Benchmarking
14.18.4 Strategic Outlook
14.19 Oracle Corporation (Oracle Life Sciences)
14.19.1 Company Snapshot
14.19.2 Company Overview
14.19.3 Financial Analysis
14.19.3.1 Net Revenue, 2022-2025
14.19.3.2 R&D, 2022-2025
14.19.3.3 Regional Market Shares, 2024
14.19.3.4 Business Segment Market Shares, 2024
14.19.4 Product Benchmarking
14.19.5 SWOT Analysis
14.19.6 Strategic Outlook
14.20 Parexel International (MA) Corporation
14.20.1 Company Snapshot
14.20.2 Company Overview
14.20.3 Product Benchmarking
14.20.4 SWOT Analysis
14.20.5 Strategic Outlook
14.21 ProPharma Group MIS Limited
14.21.1 Company Snapshot
14.21.2 Company Overview
14.21.3 Product Benchmarking
14.21.4 Strategic Outlook
14.22 Science 37 Holdings, Inc.
14.22.1 Company Snapshot
14.22.2 Company Overview
14.22.3 Product Benchmarking
14.22.4 Strategic Outlook
14.23 Signant Health
14.23.1 Company Snapshot
14.23.2 Company Overview
14.23.3 Product Benchmarking
14.23.4 Strategic Outlook
14.24 Syneos Health
14.24.1 Company Snapshot
14.24.2 Company Overview
14.24.3 Product Benchmarking
14.24.4 Strategic Outlook
14.25 Thermo Fisher Scientific Inc.
14.25.1 Company Snapshot
14.25.2 Company Overview
14.25.3 Financial Analysis
14.25.3.1 Net Revenue, 2022-2025
14.25.3.2 R&D, 2022-2025
14.25.3.3 Regional Market Shares, 2024
14.25.3.4 Business Segment Market Shares, 2024
14.25.4 Product Benchmarking
14.25.5 SWOT Analysis
14.25.6 Strategic Outlook
14.26 TFS HealthScience
14.26.1 Company Snapshot
14.26.2 Company Overview
14.26.3 Product Benchmarking
14.26.4 Strategic Outlook
14.27 THREAD Research
14.27.1 Company Snapshot
14.27.2 Company Overview
14.27.3 Product Benchmarking
14.27.4 Strategic Outlook
14.28 Veeva Systems Inc.
14.28.1 Company Snapshot
14.28.2 Company Overview
14.28.3 Financial Analysis
14.28.3.1 Net Revenue, 2022-2025
14.28.3.2 R&D, 2021-2024
14.28.3.3 Regional Market Shares, 2025
14.28.3.4 Business Segment Market Shares, 2025
14.28.4 Product Benchmarking
14.28.5 SWOT Analysis
14.28.6 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

 

ページTOPに戻る



List of Tables/Graphs

List of Tables
Table 1 Decentralised Clinical Trials Market Snapshot, 2026 & 2036 (US$ Million, CAGR %)
Table 2 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: V- Shaped Recovery Scenario
Table 3 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: U- Shaped Recovery Scenario
Table 4 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: L- Shaped Recovery Scenario
Table 5 Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 6 Interventional Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 7 Observational Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 8 Expanded Access Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 9 Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 10 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 11 Cardiovascular Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 12 Immunology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 13 Respiratory Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 14 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 15 Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 16 Telemedicine Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 17 Mobile Healthcare Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 18 Wearable Devices Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 19 Web-based Technology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 20 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 21 Decentralised Clinical Trials Market Forecast by End-User, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 22 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 23 Clinical Research Organisations (CROs) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 24 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 25 Decentralised Clinical Trials Market Forecast by Region, 2026-2036 (US$ Million, AGR%, CAGR%)
Table 26 North America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 27 North America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 28 North America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 29 North America Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 30 North America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 31 U.S. Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 32 Canada Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 33 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 34 Europe Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 35 Europe Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 36 Europe Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 37 Europe Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 38 Germany Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 39 France Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 40 UK Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 41 Italy Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 42 Spain Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 43 Russia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 44 Poland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 45 Belgium Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 46 Switzerland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 47 Netherland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 48 Rest of Europe Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 49 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 50 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 51 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 52 Asia Pacific Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 53 Asia Pacific Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 54 Japan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 55 China Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 56 India Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 57 Australia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 58 South Korea Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 59 Singapore Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 60 Taiwan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 61 New Zealand Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 62 Malaysia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 63 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 64 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 65 Latin America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 66 Latin America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 67 Latin America Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 68 Latin America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 69 Brazil Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 70 Mexico Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 71 Argentina Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 72 Colombia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 73 Chile Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 74 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 75 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 76 MEA Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 77 MEA Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 78 MEA Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 79 MEA Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 80 GCC Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 81 South Africa Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 82 Egypt Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 83 Rest of MEA Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 84 Strategic Outlook
Table 85 4G Clinical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 4G Clinical: Product Benchmarking
Table 87 4G Clinical: Strategic Outlook
Table 88 Advarra Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Advarra Inc.: Product Benchmarking
Table 90 Advarra: Strategic Outlook
Table 91 Castor: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Castor: Solutions Benchmarking
Table 93 Castor: Strategic Outlook
Table 94 Clario: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Clario: Solutions Benchmarking
Table 96 Clario: Strategic Outlook
Table 97 Clinical Ink: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Clinical Ink: Solutions Benchmarking
Table 99 Clinical Ink: Strategic Outlook
Table 100 Cloudzbyz, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Cloudzbyz, Inc.: Product Benchmarking
Table 102 Cloudzbyz, Inc.: Strategic Outlook
Table 103 Dassault Systemes SE (Medidata Solutions, Inc.): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Dassault Systemes SE (Medidata Solutions, Inc.): Product Benchmarking
Table 105 Dassault Systemes SE (Medidata Solutions, Inc.): SWOT Analysis
Table 106 Dassault Systemes SE (Medidata Solutions, Inc.): Strategic Outlook
Table 107 Ergomed Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Ergomed Group: Product Benchmarking
Table 109 Ergomed Group: Strategic Outlook
Table 110 Florence Healthcare, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Florence Healthcare, Inc.: Product Benchmarking
Table 112 Florence Healthcare, Inc.: Strategic Outlook
Table 113 Icon Plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Icon Plc: Product Benchmarking
Table 115 Icon Plc: SWOT Analysis
Table 116 Icon Plc: Strategic Outlook
Table 117 Iqvia Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Iqvia Inc.: Product Benchmarking
Table 119 Iqvia Inc.: SWOT Analysis
Table 120 Iqvia Inc.: Strategic Outlook
Table 121 KORE Wireless Group, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 KORE Wireless Group, Inc.: Product Benchmarking
Table 123 KORE Wireless Group, Inc.: SWOT Analysis
Table 124 KORE Wireless Group, Inc.: Strategic Outlook
Table 125 Labcorp Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Labcorp Holdings: Product Benchmarking
Table 127 Labcorp Holdings: SWOT Analysis
Table 128 Labcorp Holdings: Strategic Outlook
Table 129 Medable Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Medable Inc.: Product Benchmarking
Table 131 Medable Inc.: Strategic Outlook
Table 132 Medrio, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Medrio, Inc.: Product Benchmarking
Table 134 Medrio, Inc.: Strategic Outlook
Table 135 Novotech Health Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Novotech Health Holdings: Product Benchmarking
Table 137 Novotech Health Holdings: Strategic Outlook
Table 138 Oracle Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 139 Oracle Life Sciences: Product Benchmarking
Table 140 Oracle Life Sciences: SWOT Analysis
Table 141 Oracle Corporation: Strategic Outlook
Table 142 Parexel International (MA) Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 143 Parexel International (MA) Corporation: Product Benchmarking
Table 144 Parexel International (MA) Corporation: SWOT Analysis
Table 145 Parexel International (MA) Corporation: Strategic Outlook
Table 146 ProPharma Group MIS Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 147 ProPharma Group MIS Limited: Product Benchmarking
Table 148 ProPharma Group MIS Limited: Strategic Outlook
Table 149 Science 37 Holdings, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 150 Science 37 Holdings, Inc.: Product Benchmarking
Table 151 Science 37 Holdings, Inc.: Strategic Outlook
Table 152 Signant Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 153 Signant Health: Product Benchmarking
Table 154 Signant Health: Strategic Outlook
Table 155 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 156 Syneos Health: Product Benchmarking
Table 157 Syneos Health: Strategic Outlook
Table 158 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 159 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 160 Thermo Fisher Scientific Inc.: SWOT Analysis
Table 161 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 162 TFS HealthScience: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 163 TFS HealthScience: Product Benchmarking
Table 164 TFS HealthScience: Strategic Outlook
Table 165 THREAD Research: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 THREAD Research: Product Benchmarking
Table 167 THREAD Research: Strategic Outlook
Table 168 Veeva Systems Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 169 Veeva Systems Inc.: Product Benchmarking
Table 170 Veeva Systems Inc.: SWOT Analysis
Table 171 Veeva Systems Inc.: Strategic Outlook

List of Figures
Figure 1 Decentralised Clinical Trials Market Segmentation
Figure 2 Decentralised Clinical Trials Market by Study-Design: Market Attractiveness Index
Figure 3 Decentralised Clinical Trials Market by Indication: Market Attractiveness Index
Figure 4 Decentralised Clinical Trials Market by Technology: Market Attractiveness Index
Figure 5 Decentralised Clinical Trials Market by End-users: Market Attractiveness Index
Figure 6 Decentralised Clinical Trials Market by Region: Market Attractiveness Index
Figure 7 Decentralised Clinical Trials Market: Market Dynamics
Figure 8 Decentralised Clinical Trials Market: Impact Analysis
Figure 9 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 10 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 11 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 12 Short Term & Long Term Planning
Figure 13 Impact of U.S. and China Trade War
Figure 14 Most Impacted Countries
Figure 15 Decentralised Clinical Trials Market: Porter’s Five Forces Analysis
Figure 16 Decentralised Clinical Trials Market: PEST Analysis
Figure 17 Decentralised Clinical Trials Market by Study Design: Market Attractiveness Index
Figure 18 Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 19 Decentralised Clinical Trials Market Share Forecast by Study Design, 2026, 2031, 2036 (%)
Figure 20 Interventional Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 21 Interventional Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 22 Observational Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 23 Observational Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 24 Expanded Access Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 25 Expanded Access Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 26 Decentralised Clinical Trials Market by Indication: Market Attractiveness Index
Figure 27 Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 28 Decentralised Clinical Trials Market Share Forecast by Indication, 2026, 2031, 2036 (%)
Figure 29 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 30 Oncology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 31 Cardiovascular Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 32 Cardiovascular Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 33 Immunology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 34 Immunology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 35 Respiratory Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 36 Respiratory Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 37 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 38 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 39 Decentralised Clinical Trials Market by Technology: Market Attractiveness Index
Figure 40 Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 41 Decentralised Clinical Trials Market Share Forecast by Technology, 2026, 2031, 2036 (%)
Figure 42 Telemedicine Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 43 Telemedicine Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 44 Mobile Healthcare Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 45 Mobile Healthcare Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 46 Wearable Devices Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 47 Wearable Devices Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 48 Web-based Technology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 49 Web-based Technology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 50 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 51 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 52 Decentralised Clinical Trials Market by End-User: Market Attractiveness Index
Figure 53 Decentralised Clinical Trials Market Forecast by End-User, 2026-2036 (US$ Billion, AGR %)
Figure 54 Decentralised Clinical Trials Market Share Forecast by End-User, 2026, 2031, 2036 (%)
Figure 55 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 56 Pharmaceutical and Biopharmaceutical Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 57 Clinical Research Organisations (CROs) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 58 Clinical Research Organisations (CROs) Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 59 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 60 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 61 Decentralised Clinical Trials Market Forecast by Region 2025 and 2036 (Revenue, CAGR%)
Figure 62 Decentralised Clinical Trials Market Share Forecast by Region 2026, 2031, 2036 (%)
Figure 63 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %)
Figure 64 North America Decentralised Clinical Trials Market Attractiveness Index
Figure 65 North America Decentralised Clinical Trials Market by Region, 2025, 2031 & 2036 (US$ Billion)
Figure 66 North America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 67 North America Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 68 North America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 69 North America Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 70 North America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 71 North America Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 72 North America Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 73 North America Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 74 North America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 75 North America Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 76 U.S. Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 77 Canada Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 78 Europe Decentralised Clinical Trials Market Attractiveness Index
Figure 79 Europe Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 80 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 81 Europe Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 82 Europe Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 83 Europe Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 84 Europe Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 85 Europe Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 86 Europe Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 87 Europe Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 88 Europe Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 89 Europe Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 90 Germany Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 91 France Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 92 UK Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 93 Italy Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 94 Spain Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 95 Russia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 96 Poland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 97 Belgium Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 98 Switzerland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 99 Netherland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 100 Rest of Europe Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 101 Asia Pacific Decentralised Clinical Trials Market Attractiveness Index
Figure 102 Asia Pacific Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 103 Asia Pacific Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 104 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 105 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 106 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 107 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 108 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 109 Asia Pacific Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 110 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 111 Asia Pacific Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 112 Asia Pacific Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 113 Japan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 114 China Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 115 India Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 116 Australia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 117 South Korea Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 118 Singapore Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 119 Taiwan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 120 New Zealand Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 121 Malaysia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 122 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 123 Latin America Decentralised Clinical Trials Market Attractiveness Index
Figure 124 Latin America Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 125 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 126 Latin America Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 127 Latin America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 128 Latin America Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 129 Latin America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 130 Latin America Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 131 Latin America Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 132 Latin America Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 133 Latin America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 134 Latin America Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 135 Brazil Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 136 Mexico Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 137 Argentina Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 138 Colombia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 139 Chile Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 140 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 141 MEA Decentralised Clinical Trials Market Attractiveness Index
Figure 142 MEA Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 143 MEA Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 144 MEA Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 145 MEA Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 146 MEA Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 147 MEA Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 148 MEA Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 149 MEA Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 150 MEA Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 151 MEA Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 152 MEA Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 153 GCC Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 154 South Africa Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 155 Egypt Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 156 Rest of MEA Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 157 Decentralised Clinical Trials Market: Company Share/Ranking, 2024
Figure 158 Dassault Systemes SE (Medidata Solutions, Inc.): Net Revenue, 2021-2024 (US$ Million, AGR%)
Figure 159 Dassault Systemes SE (Medidata Solutions, Inc.): R&D, 2021-2024 (US$ Million, AGR%)
Figure 160 Dassault Systemes SE (Medidata Solutions, Inc.): Regional Market Shares, 2024
Figure 161 Dassault Systemes SE (Medidata Solutions, Inc.): Business Segment Market Shares, 2024
Figure 162 Icon Plc: Net Revenue, 2021-2024 (US$ Million, AGR%)
Figure 163 Icon Plc: Regional Market Shares, 2024
Figure 164 Iqvia Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 165 Iqvia Inc.: Regional Market Shares, 2024
Figure 166 Iqvia Inc.: Business Segment Market Shares, 2025
Figure 167 KORE Wireless Group, Inc.: Net Revenue, 2021-2024 (US$ Million, AGR%)
Figure 168 KORE Wireless Group, Inc.: Regional Market Shares, 2024
Figure 169 KORE Wireless Group, Inc.: Business Segment Market Shares, 2024
Figure 170 Labcorp Holdings: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 171 Labcorp Holdings: Regional Market Shares, 2024
Figure 172 Labcorp Holdings: Business Segment Market Shares, 2024
Figure 173 Oracle Life Sciences: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 174 Oracle Life Sciences: R&D, 2022-2025 (US$ Million, AGR%)
Figure 175 Oracle Life Sciences: Regional Market Shares, 2025
Figure 176 Oracle Life Sciences: Business Segment Market Shares, 2025
Figure 177 Thermo Fisher Scientific Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 178 Thermo Fisher Scientific Inc.: R&D, 2022-2025 (US$ Million, AGR%)
Figure 179 Thermo Fisher Scientific Inc.: Regional Market Shares, 2024
Figure 180 Thermo Fisher Scientific Inc.: Business Segment Market Shares, 2024
Figure 181 Veeva Systems Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 182 Veeva Systems Inc.: R&D, 2022-2025 (US$ Million, AGR%)
Figure 183 Veeva Systems Inc.: Regional Market Shares, 2025
Figure 184 Veeva Systems Inc.: Business Segment Market Shares, 2025

 

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療IT）の最新刊レポート

Visiongain社の ヘルスケアと医薬・化学品分野 での最新刊レポート

本レポートと同じKEY WORD（clinical trials）の最新刊レポート


よくあるご質問


Visiongain社はどのような調査会社ですか?


英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

当社ご利用のメリット
  1. ① お探しの情報に合わせてレポートをご紹介
  2. ② レポートで不足している情報はカスタマイズで対応可能
  3. ③ 特許情報、海外の法規制の取り組みなどディープな調査も対応可能
  4. ④ 円貨で請求書払い＆万全のアフターフォロー

 

2026/04/28　10:26

160.54 円

188.43 円

219.87 円

ページTOPに戻る

株式会社 データリソース　Data Resource, Inc.
東京都千代田区丸の内3-3-1 新東京ビル4F 430


A member of CORSS Business Producers Inc.
データリソースは2025年5月より
CROSS Business Producers株式会社 の100%子会社になりました。

電話：03-3582-2531
FAX：03-6551-2556
Eメール：office@dri.co.jp

会社概要 FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2025　DATA RESOURCE, Inc. ALL RIGHTS RESERVED.